Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07353801
PHASE4

Oral Mini Pulse Dexamethasone in Pediatric Vitiligo

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if oral mini pulse (OMP) dexamethasone works to treat active vitiligo in children and also learn about the safety of this drug within this age group the main questions it aims to answer are does OMP halt activity in active vitiligo and what medical problems patients might experience while using the drug with special attention to linear growth. Researchers will give OMP dexamethasone to participating patients to see if the drug works to treat active vitiligo and whether it has any effect on linear growth. Participants will take OMP dexamethasone two fixed days per week for a period of 3 months. before starting treatment, patients will do baseline evaluation and investigations then monthly evaluation to monitor progress, report any side effects at the end of treatment period response to drug, lab values and growth will be evaluated then final evaluation of growth will be done after stoppage of drug.

Official title: The Efficacy and Safety of Oral Mini-pulse Dexamethasone in Active Non-segmental Vitiligo Within the Pediatric Age Group

Key Details

Gender

All

Age Range

4 Years - 9 Years

Study Type

INTERVENTIONAL

Enrollment

22

Start Date

2026-02-28

Completion Date

2026-07

Last Updated

2026-03-03

Healthy Volunteers

No

Conditions

Interventions

DRUG

Dexamethasone (0.1 mg/kg)

patients will receive oral mini pulse dexamethasone 2 fixed consecutive days per week in a dose of 0.1mg/kg/day for a period of 3 months

Locations (1)

Dermatology Outpatient Clinic, Kasr al Ainy Teaching Hospital, Cairo University

Cairo, Egypt